Alfacalcidol Strides Pharma

Medicinal product

(Invented) name

Alfacalcidol Strides Pharma

Active substance (s)

Alfakalcidolis

Strength

0,25 µg

Pharmaceutical form

minkštosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A11CC03, Alfacalcidol

Marketing authorisation holder

Strides Pharma (Cyprus) Limited, Kipras

Date of authorisation

2022-12-19

Date of renewal

Documents

5080_5082 Alfacalcidol Strides Pharma PCS PL 2023 10 20.docx

5080_5082 Pakuotės lapelis 2023 10 20.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

FI/H/1042/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Alfakalcidolis	0,25 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109975	96085	1096085	talpyklė	N30		Receptinis	LT/1/22/5080/001	Netiekiama	-	-	No	-	-
109976	96086	1096086	talpyklė	N50		Receptinis	LT/1/22/5080/002	Netiekiama	-	-	No	-	-
109977	96087	1096087	talpyklė	N90		Receptinis	LT/1/22/5080/003	Netiekiama	-	-	No	-	-
109978	96088	1096088	talpyklė	N100		Receptinis	LT/1/22/5080/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-12-19	Registruotas